Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7974149, 10 pages
Research Article

Δ9-Tetrahydrocannabinol Prevents Cardiovascular Dysfunction in STZ-Diabetic Wistar-Kyoto Rats

School of Health, Medical and Applied Sciences, Central Queensland University, Rockhampton, QLD, Australia

Correspondence should be addressed to Rebecca K. Vella; ua.ude.uqc@allev.r

Received 29 April 2017; Accepted 1 August 2017; Published 18 October 2017

Academic Editor: Hanrui Zhang

Copyright © 2017 Rebecca K. Vella et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • Michał Biernacki, Barbara Malinowska, Magdalena Timoszuk, Martek Toczek, Anna Jastrząb, Patryk Remiszewski, and Elżbieta Skrzydlewska, “Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma,” Prostaglandins & Other Lipid Mediators, 2018. View at Publisher · View at Google Scholar
  • Bharath Kumar Velmurugan, “Therapeutic applications of cannabinoids,” Chemico-Biological Interactions, 2018. View at Publisher · View at Google Scholar
  • Alisa Bahar Beydogan, Zeynep Mine Coskun, and Sema Bolkent, “ The protective effects of Δ 9 -tetrahydrocannabinol against inflammation and oxidative stress in rat liver with fructose-induced hyperinsulinemia ,” Journal of Pharmacy and Pharmacology, 2018. View at Publisher · View at Google Scholar
  • Emily Brook, John Mamo, Rachel Wong, Hani Al-Salami, Marco Falasca, Virginie Lam, and Ryusuke Takechi, “Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids,” Pharmacological Research, 2019. View at Publisher · View at Google Scholar